Articles

Showing 3 articles

• Original Research

  Published 12 October 2026

  Taxifolin alleviates podocyte injury and macrophage chemotaxis associated with diabetic nephropathy by directly targeting RBP1 identified via multi-omics and machine learning

  Zi-Xuan Wang · Wen-Xuan Wang · Qiong-Dan Liang · Ling-Dong Kong

  Frontiers in Pharmacology

  doi 10.3389/fphar.2026.1933167

• Review

  Published 9 October 2026

  Metabolic reprogramming and metabolic homeostasis in podocyte injury: novel mechanistic insights and natural product therapies

  Zhongjie Qu · Wenqing Ba · Meijing Tang · Wenze Jiang · Mengting Zhu · Keda Lu

  Frontiers in Cell and Developmental Biology

  doi 10.3389/fcell.2026.1978760

• Review

  Published 25 August 2026

  Translational advances in diabetic nephropathy management: integrating nanoformulation-based drug delivery systems

  Mohd Danish Ansari · Ashish Vishwakarma · Md Quamuddin · Mansi Aggarwal · Hashim Khan · Muhammad Fauzi Abd Jalil · Syed Mahmood · Adil Farooq Wali · Sirajunisa Talath · Mohamed El-Tanani

  Frontiers in Medical Technology

  doi 10.3389/fmedt.2026.1951734